[{"indications": "Indications\u00a0see under Dose", "name": "ESOMEPRAZOLE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.3 Antisecretory drugs and mucosal protectants", "1.3.5 Proton pump inhibitors", "ESOMEPRAZOLE"], "cautions": "Cautions\u00a0\n(From 1.3.5 Proton pump inhibitors: British National Formulary)\nCautions\u00a0Proton pump inhibitors may mask the symptoms of gastric cancer; particular care is required in those presenting with \u2018alarm features\u2019 (see Dyspepsia), in such cases gastric malignancy should be ruled out before treatment. A proton pump inhibitor should be prescribed for appropriate indications at the lowest effective dose for the shortest period; the need for long-term treatment should be reviewed periodically.; interactions: Appendix 1 (proton pump inhibitors)", "side-effects": "Side-effects\u00a0\n(From 1.3.5 Proton pump inhibitors: British National Formulary)\nSide-effects\u00a0Side-effects of the proton pump inhibitors include gastro-intestinal disturbances (including nausea, vomiting, abdominal pain, flatulence, diarrhoea, constipation), and headache. Less frequent side-effects include dry mouth, peripheral oedema, dizziness, sleep disturbances, fatigue, paraesthesia, arthralgia, myalgia, rash, and pruritus. Other side-effects reported rarely or very rarely include taste disturbance, stomatitis, hepatitis, jaundice, hypersensitivity reactions (including anaphylaxis, bronchospasm), fever, depression, hallucinations, confusion, gynaecomastia, interstitial nephritis, hyponatraemia, hypomagnesaemia (with long-term treatment), blood disorders (including leucopenia, leucocytosis, pancytopenia, thrombocytopenia), visual disturbances, sweating, photosensitivity, alopecia, Stevens-Johnson syndrome, and toxic epidermal necrolysis. By decreasing gastric acidity, proton pump inhibitors may increase the risk of gastro-intestinal infections (including Clostridium difficile infection).Rebound acid hypersecretion and protracted dyspepsia may occur after stopping prolonged treatment with a proton pump inhibitor.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/88869.htm", "doses": ["By mouth duodenal ulcer associated\r\nwith Helicobacter pylori, see Recommended Regimens for Helicobacter pylori Eradication", "NSAID-associated gastric ulcer, adult over 18 years, 20\u00a0mg once daily for 4\u20138 weeks; prophylaxis in patients\r\nwith an increased risk of gastroduodenal complications who require\r\ncontinued NSAID treatment, 20\u00a0mg daily", "Gastro-oesophageal reflux disease (in the presence of erosive\r\nreflux oesophagitis), adult and child over 12 years, 40\u00a0mg once daily for 4 weeks,\r\ncontinued for further 4 weeks if not fully healed or symptoms persist;\r\nmaintenance 20\u00a0mg daily; child 1\u201312\r\nyears, body-weight 10\u201320\u00a0kg, 10\u00a0mg once daily for 8 weeks; body-weight\r\nover 20\u00a0kg, 10\u201320\u00a0mg once daily for 8 weeks", "Symptomatic treatment of gastro-oesophageal reflux disease (in\r\nthe absence of oesophagitis), adult and child over 12 years, 20\u00a0mg once\r\ndaily for up to 4 weeks, then 20\u00a0mg daily when required; child 1\u201312 years, body-weight over 10\u00a0kg, 10\u00a0mg once\r\ndaily for up to 8 weeks", "Zollinger\u2013Ellison syndrome, adult over 18 years, initially 40\u00a0mg twice daily, adjusted according to\r\nresponse; usual range 80\u2013160\u00a0mg daily (above 80\u00a0mg in 2 divided doses)", "By intravenous injection over at\r\nleast 3 minutes or by intravenous infusion, adult over 18 years, gastro-oesophageal\r\nreflux disease, 40\u00a0mg once daily; symptomatic reflux disease without\r\noesophagitis, treatment of NSAID-associated gastric ulcer, prevention\r\nof NSAID-associated gastric or duodenal ulcer, 20\u00a0mg daily; continue\r\nuntil oral administration possible", "Severe peptic ulcer bleeding (following endoscopic\r\ntreatment), adult over 18 years, initial intravenous infusion of 80\u00a0mg over 30 minutes, then by continuous intravenous infusion 8\u00a0mg/hour for 72 hours,\r\nthen by mouth 40\u00a0mg once daily for 4 weeks"], "pregnancy": "Pregnancy\u00a0manufacturer advises caution\u2014no information available"}]